First Time Loading...

Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT

Watchlist Manager
Arcturus Therapeutics Holdings Inc Logo
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Watchlist
Price: 27.485 USD 1.01%
Updated: May 9, 2024

EV/EBITDA
Enterprise Value to EBITDA

-6.1
Current
-1.8
Median
4.5
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-6.1
=
Enterprise Value
459.7m
/
EBITDA
-75.2m
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-12.6
2-Years Forward
EV/EBITDA
-34.1
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More